drugset / Trial / NCT02000219
Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis
Phase 2
Completed
12 enrolled
OxThera
FP7-SME-2013 Research for the benefit of SMEs program · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if Oxalobacter formigenes is effective at lowering plasma oxalate levels in patients with primary hyperoxaluria who are on dialysis.
Timeline
- Start
- 2014-05-19
- Primary completion
- 2020-01-29
- Completion
- 2020-01-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxalobacter formigenes | Other / unclassified | 1e+09 unknown | Oral |